Does ROMIPLOSTIM Cause Thrombocytosis? 234 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 234 reports of Thrombocytosis have been filed in association with ROMIPLOSTIM (Nplate). This represents 3.1% of all adverse event reports for ROMIPLOSTIM.
234
Reports of Thrombocytosis with ROMIPLOSTIM
3.1%
of all ROMIPLOSTIM reports
10
Deaths
103
Hospitalizations
How Dangerous Is Thrombocytosis From ROMIPLOSTIM?
Of the 234 reports, 10 (4.3%) resulted in death, 103 (44.0%) required hospitalization, and 16 (6.8%) were considered life-threatening.
Is Thrombocytosis Listed in the Official Label?
Yes, Thrombocytosis is listed as a known adverse reaction in the official FDA drug label for ROMIPLOSTIM.
What Other Side Effects Does ROMIPLOSTIM Cause?
Off label use (1,027)
Platelet count decreased (892)
Platelet count abnormal (703)
Drug ineffective (513)
Thrombocytopenia (369)
Headache (359)
Death (356)
Product storage error (344)
Fatigue (251)
Circumstance or information capable of leading to medication error (238)
What Other Drugs Cause Thrombocytosis?
RUXOLITINIB (179)
METHOTREXATE (135)
CLOZAPINE (123)
ADALIMUMAB (94)
GEMCITABINE (71)
PREDNISONE (71)
GEMCITABINE\GEMCITABINE (67)
PACLITAXEL (64)
CARBOPLATIN (63)
ELTROMBOPAG (58)
Which ROMIPLOSTIM Alternatives Have Lower Thrombocytosis Risk?
ROMIPLOSTIM vs ROMOSOZUMAB
ROMIPLOSTIM vs ROMOSOZUMAB-AQQG
ROMIPLOSTIM vs ROPEGINTERFERON ALFA-2B-NJFT
ROMIPLOSTIM vs ROPINIROLE
ROMIPLOSTIM vs ROPIVACAINE